ArticleCell death discovery2021

Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer.

Chuncao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.